Xin Guo
About Xin Guo
Xin Guo serves as the VP of Bioinformatics and Co-founder at Apostle, Inc., where he developed an algorithm to improve cancer diagnostic tools. He has a strong academic background, holding a PhD in Computer Science from Duke University and has previously worked at Gilead Sciences as a Research Scientist II.
Work at Apostle
Xin Guo serves as the Vice President of Bioinformatics and Co-Founder at Apostle, Inc. since 2017. In this role, Xin has developed a novel algorithm that enhances the precision of cancer diagnostic tools. Apostle, Inc. operates in the biotechnology sector, focusing on innovative solutions for cancer diagnostics and treatment.
Previous Experience at Gilead Sciences
Prior to joining Apostle, Xin Guo worked at Gilead Sciences as a Research Scientist II from 2012 to 2016. During this four-year tenure in Foster City, CA, Xin contributed to various research initiatives, gaining valuable experience in the biotechnology field.
Education and Expertise
Xin Guo holds multiple degrees in computer science and informatics. Xin earned a Master of Science in Computer Science from the Tokyo Institute of Technology and a Master of Science in Informatics from Universität des Saarlandes. Additionally, Xin completed a PhD in Computer Science, focusing on computational biology and machine learning at Duke University. Xin also holds a Bachelor of Engineering in Network Informatics from Chiba Institute of Technology.
Research Contributions and Patents
Xin Guo holds a patent related to bioinformatics applications in cancer diagnostics. Xin has co-authored a research paper on AI-enabled nanoDiagnostics technology aimed at early-stage cancer detection. These contributions reflect a commitment to advancing the field of bioinformatics and improving cancer diagnostic methods.
Mentorship and Community Engagement
Xin Guo actively participates in mentoring young professionals in bioinformatics through a local tech mentorship program. Additionally, Xin has participated in a panel discussion on the future of bioinformatics at a major biotechnology conference, sharing insights and expertise with peers in the industry.